Studying the Effects of Sibutramine on Eating Behavior.

Trial Profile

Studying the Effects of Sibutramine on Eating Behavior.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Sibutramine (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Feb 2012 Actual end date 1 Oct 2010 added as reported by ClinicalTrials.gov.
    • 27 Feb 2012 Actual initiation date Feb 2009 and patient number 17 added as reported by ClinicalTrials.gov.
    • 27 Feb 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top